Sugammadex Injection, Solution
Product Images NDC 72266-269

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Sugammadex (NDC 72266-269). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Fosun Pharma Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carton (2ml Carton)

Packaging label for Sugammadex Injection 200 mg/2 mL (100 mg/mL) single-dose vials. The label indicates 10 vials per package, for intravenous use only, and is manufactured by Fosun Pharma USA Inc. Barcode, storage instructions, and drug use details are also visible on the label.*

FDA Label Image

Carton (5ml Carton)

Packaging label for Sugammadex Injection 500 mg/5 mL (100 mg/mL) solution for intravenous use. The label indicates a package containing 10 single-dose vials of 5 mL each. The product is labeled by Fosun Pharma USA Inc. with the NDC number 72266-269-10.*

FDA Label Image

Sugammadex-spl-image-1 (Sugammadex Spl Image 1)

A cumulative recovery rate graph comparing recovery times for sugammadex and neostigmine. The x-axis represents time to recovery in minutes, and the y-axis shows cumulative recovery rate from 0 to 1. Sugammadex achieves higher recovery rates faster than neostigmine, with median recovery times of 1.4 minutes and 21.5 minutes respectively, as indicated in the inset.*

FDA Label Image

Sugammadex-spl-image-2 (Sugammadex Spl Image 2)

A line graph displaying cumulative recovery rate over time (minutes) for sugammadex and neostigmine. Two curves compare recovery rates, with sugammadex showing a faster recovery. A legend box includes median recovery times (sugammadex 2.1 min, neostigmine 29.0 min). Axes are labeled: cumulative recovery rate (y-axis) and time to recovery in minutes (x-axis).*

FDA Label Image

Sugammadex-spl-structure-1 (Sugammadex Spl Structure 1)

Chemical structure diagram depicting the molecular framework of sugammadex, showing its cyclic and functional group arrangement consistent with its sodium salt form.*

FDA Label Image

Sugammadex-spl-structure-2 (Sugammadex Spl Structure 2)

Chemical structure of sugammadex.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.